Ghent University Academic Bibliography

Guideline adherence and survival of patients with candidaemia in Europe : results from the ECMM Candida III multinational European observational cohort study

Martin Hoenigl, Jon Salmanton-García, Matthias Egger, Jean-Pierre Gangneux, Tihana Bicanic, Sevtap Arikan-Akdagli, Ana Alastruey-Izquierdo, Nikolai Klimko, Aleksandra Barac, Volkan Özenci, et al.

(2023) LANCET INFECTIOUS DISEASES. 23(6). p.751-761

Add to list

Journal Article
A1
open access

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial

Isabel Leroux-Roels (UGent) , Paul Willems, Gwenn Waerlop (UGent) , Yorick Janssens (UGent) , Jessika Tourneur, Fien De Boever (UGent) , Jacques Bruhwyler, Azhar Alhatemi (UGent) , Bart Jacobs (UGent) , Florence Nicolas, et al.

(2023) LANCET INFECTIOUS DISEASES.

Add to list

Infection control in the intensive care unit : expert consensus statements for SARS-CoV-2 using a Delphi method

Prashant Nasa, Elie Azoulay, Arunaloke Chakrabarti, Jigeeshu V Divatia, Ravi Jain, Camilla Rodrigues, Victor D Rosenthal, Waleed Alhazzani, Yaseen M Arabi, Jan Bakker, et al.

(2022) LANCET INFECTIOUS DISEASES. 22(3). p.e74-e87

Add to list

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD) : a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andres Ahuad Guerrero, Eunate Arana-Arri, Gustavo Jose Aroca Martinez, Marc Bonten, Reynaldo Chandler, Gonzalo Corral, Eddie Jan Louis De Block, Lucie Ecker, Julian Justin Gabor, et al.

(2022) LANCET INFECTIOUS DISEASES. 22(3). p.329-340

Add to list

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

Karin Hardt, An Vandebosch, Jerald Sadoff, Mathieu Le Gars, Carla Truyers, David Lowson, Ilse Van Dromme, Johan Vingerhoets, Tobias Kamphuis, Gert Scheper, et al.

(2022) LANCET INFECTIOUS DISEASES. 22(12). p.1703-1715

Add to list

Miscellaneous

Herpetic oesophagitis in an immunocompetent infant with gastroesophageal reflux

EJE Peeters, Pauline De Bruyne (UGent) , M Van Waas, JC Escher, M Doukas, DM Hendriks and CEV Esch

(2021) LANCET INFECTIOUS DISEASES. 21(9). p.1332-1332

Add to list

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT) : a randomised, double-blind, phase 3 trial

T Vesikari, JM Langley, N Segall, BJ Ward, C Cooper, G Poliquin, B Smith, S Gantt, JE McElhaney, M Dionne, et al.

(2021) LANCET INFECTIOUS DISEASES. 21(9). p.1271-1281

Add to list

Journal Article
A1
open access

Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin : a systematic review

Nadine K Kayiba, Doudou M Yobi, Evariste Tshibangu-Kabamba, Vo P Tuan, Yoshio Yamaoka, Brecht Devleesschauwer (UGent) , Dieudonné M Mvumbi, Emile Okitolonda Wemakoy, Patrick De Mol, Georges L Mvumbi, et al.

(2021) LANCET INFECTIOUS DISEASES. 21(4). p.e82-e92

Add to list

Miscellaneous

Emerging macrolide resistance in Mycoplasma genitalium

Piet Cools (UGent) and Elizaveta Padalko (UGent)

(2020) LANCET INFECTIOUS DISEASES. 20(11). p.1222-1223

Add to list

Global burden of melioidosis in 2015 : a systematic review and data synthesis

Emma Birnie, Harjeet S Virk, Jelmer Savelkoel, Rene Spijker, Eric Bertherat, David AB Dance, Direk Limmathurotsakul, Brecht Devleesschauwer (UGent) , Juanita A Haagsma and W Joost Wiersinga

(2019) LANCET INFECTIOUS DISEASES. 19(8). p.892-902

Academic Bibliography

Guideline adherence and survival of patients with candidaemia in Europe : results from the ECMM Candida III multinational European observational cohort study

Immunogenicity, safety, and preliminary efficacy evaluation of OVX836, a nucleoprotein-based universal influenza A vaccine candidate : a randomised, double-blind, placebo-controlled, phase 2a trial

Infection control in the intensive care unit : expert consensus statements for SARS-CoV-2 using a Delphi method

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD) : a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Efficacy, safety, and immunogenicity of a booster regimen of Ad26.COV2.S vaccine against COVID-19 (ENSEMBLE2) : results of a randomised, double-blind, placebo-controlled, phase 3 trial

Herpetic oesophagitis in an immunocompetent infant with gastroesophageal reflux

Immunogenicity and safety of a tri-antigenic versus a mono-antigenic hepatitis B vaccine in adults (PROTECT) : a randomised, double-blind, phase 3 trial

Spatial and molecular mapping of Pfkelch13 gene polymorphism in Africa in the era of emerging Plasmodium falciparum resistance to artemisinin : a systematic review

Emerging macrolide resistance in Mycoplasma genitalium

Global burden of melioidosis in 2015 : a systematic review and data synthesis

Contents

Support

Contact